Cameron Pharmaceuticals
4 drugs in NADAC|4 Generic,0 Brand
Cameron Pharmaceuticals lists 4 NDCs in the CMS NADAC file (4 generic, 0 brand), at an average NADAC of $1.35 per unit, with a week-over-week move of +1.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
4G / 0B
Avg Price / Unit
$1.3466
$0.22 – $2.55
Avg 7d Change
+1.12%
Across 4 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Acetylcysteine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Antidote therapeutic class
Review the broader class where Cameron Pharmaceuticals has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Cameron Pharmaceuticals make?
Cameron Pharmaceuticals lists 4 NDCs in the CMS NADAC file — 4 generic and 0 brand products.
What is the average price of Cameron Pharmaceuticals drugs?
The average NADAC across Cameron Pharmaceuticals's portfolio is $1.3466 per unit, ranging from $0.2186 to $2.5539.
What types of drugs does Cameron Pharmaceuticals make?
Cameron Pharmaceuticals makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Antidote (2), Antidote for Acetaminophen Overdose (2), Mucolytic (2), Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor (2).
Has Cameron Pharmaceuticals had any drug recalls?
No FDA enforcement recalls are matched to Cameron Pharmaceuticals in the openFDA feed.
How has Cameron Pharmaceuticals's pricing changed recently?
Over the past 7 days, 3 Cameron Pharmaceuticals products rose and 1 fell, with a portfolio-wide average change of +1.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) Acetylcysteine | $2.5539 per ML | -2.48% |
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) Acetylcysteine | $2.2455 per ML | +3.80% |
ENTECAVIR 1 MG TABLET ENTECAVIR ANHYDROUS | $0.3684 per EA | +0.73% |
ENTECAVIR 0.5 MG TABLET ENTECAVIR ANHYDROUS | $0.2186 per EA | +2.41% |